NOVEL COMPOUNDS FOR TREATMENT OF CYSTIC FIBROSIS

A corrector agent capable of stabilizing a newly synthesized cystic fibrosis transmembrane conductance regulator (CFTR) protein, useful in the treatment of cystic fibrosis. L'invention concerne un agent correcteur capable de stabiliser une protéine régulatrice nouvellement synthétisée de la con...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DE WILDE, Gert Jules Hector, KYM, Philip R, MENET, Christel Jeanne Marie, GOSMINI, Romain Luc Marie, CONRATH, Katja E, SWIFT, Elizabeth C, WANG, Xueqing, LEFRANCOIS, Jean-Michel, BOCK, Xavier Marie, JANSEN, Koen Karel, MERAYO, Nuria Merayo, HOUSSEMAN, Christopher Gaëtan, PALISSE, Adeline Marie Elise, PIZZONERO, Mathieu Rafaël, DE LEMOS, Elsa, AKKARI, Rhalid, DESROY, Nicolas, CYR, Douglas, CLAES, Pieter Isabelle Roger, VAN DER PLAS, Steven Emiel, PATEL, Sachin V, COWART, Marlon D, SHRESTHA, Anurupa, BROWN, Brian S, NEWSOME, Gregory John Robert, DUTHION, Béranger, GFESSER, Gregory A, MAMMOLITI, Oscar, JI, Jianguo, ALVEY, Luke Jonathan, TSE, Chris
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A corrector agent capable of stabilizing a newly synthesized cystic fibrosis transmembrane conductance regulator (CFTR) protein, useful in the treatment of cystic fibrosis. L'invention concerne un agent correcteur capable de stabiliser une protéine régulatrice nouvellement synthétisée de la conductance transmembranaire de la fibrose kystique (CFTR), utile dans le traitement de la fibrose kystique.